Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MGI Announces Commercial Availability of HotMPS Sequencing Chemistry*and Instrument**in the United Kingdom 2022-08-04 22:50
Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector 2022-08-04 22:01
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA 2022-08-04 08:10
HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA 2022-08-03 20:00
HIGHLIGHTS FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 2022-08-03 20:00
TikoMed's ILB® activates the body's natural repair signals to restore glutamate homeostasis, amino acid metabolism and neurocognitive functions in a rat model of severe traumatic brain injury 2022-08-03 17:23
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients 2022-08-03 16:50
Technology Solutions to Boost Employee Experience and Improve Patient Outcomes 2022-08-03 15:12
Yidu Tech Releases FY2022 ESG Report, Using Socially Beneficial Technology to Drive the Sustainable Development of "Green Healthcare" 2022-08-03 15:09
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya 2022-08-03 14:00
Lim Chin Hau and Medicap Sdn Bhd Awarded at the Asia Pacific Enterprise Awards 2022 Malaysia 2022-08-03 13:12
Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines 2022-08-03 13:09
Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma 2022-08-03 08:30
Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 Clinical Trial of XW003 (Ecnoglutide), a novel long-lasting GLP-1 analogue, in Adult Patients with Type 2 Diabetes in China 2022-08-03 08:00
Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China 2022-08-03 08:00
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies 2022-08-03 08:00
LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE 2022-08-03 00:15
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination 2022-08-02 22:49
Metabolon Awarded ISO 9001:2015 Recertification 2022-08-02 20:57
Sironax Announces Closing of $200 Million Series B Financing 2022-08-02 19:00
1 132 133 134 135 136 492